Tags

Type your tag names separated by a space and hit enter

Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians.
Prev Med. 2011 Jan; 52(1):10-5.PM

Abstract

OBJECTIVE

To examine US physicians' self-reported knowledge about the Polypill, factors considered in deciding whether to prescribe it, and acceptance of prescribing it for cardiovascular disease (CVD) prevention.

METHODS

Numerical scales of 0 (lowest) to 5 (highest) were used to assess self-reported knowledge and importance of factors relevant to making a decision to prescribe a Polypill. Characteristics of physicians indicating they would prescribe a Polypill were compared.

RESULTS

Among 952 physicians surveyed February through March 2010, mean self-rated knowledge about the Polypill was 2.0±1.5. Importance of degree of CVD event reduction, cost, and side effects were rated with means of 4.4, 4.3, and 4.3, respectively. 83% of respondents indicated they would "definitely" or "probably" prescribe it for high-risk patients; 62% would do so for moderate risk patients. Physicians with self-rated knowledge at ≥75th percentile were more likely to indicate they would prescribe a Polypill for moderate risk (adjusted OR 2.16; 95% CI 1.60-2.93) and high-risk (adjusted OR 1.57; 95% CI 1.07-2.32) patients.

CONCLUSION

Among this sample of physicians, there is relatively high acceptance of prescribing a Polypill for CVD prevention despite relatively modest knowledge about it.

Links

PMC Free PDF
PMC Free Full Text
Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Viera AJ
Department of Family Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA. anthony_viera@med.unc.edu
Sheridan SL
No affiliation info available
Edwards T
No affiliation info available
Soliman EZ
No affiliation info available
Harris R
No affiliation info available
Furberg CD
No affiliation info available

MeSH

Antihypertensive AgentsAspirinCardiovascular DiseasesDrug CombinationsFemaleFolic AcidHealth Care SurveysHealth Knowledge, Attitudes, PracticeHematinicsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMalePlatelet Aggregation InhibitorsPractice Patterns, Physicians'Primary PreventionUnited States

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

20933538

Citation

Viera, Anthony J., et al. "Acceptance of a Polypill Approach to Prevent Cardiovascular Disease Among a Sample of U.S. Physicians." Preventive Medicine, vol. 52, no. 1, 2011, pp. 10-5.
Viera AJ, Sheridan SL, Edwards T, et al. Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians. Prev Med. 2011;52(1):10-5.
Viera, A. J., Sheridan, S. L., Edwards, T., Soliman, E. Z., Harris, R., & Furberg, C. D. (2011). Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians. Preventive Medicine, 52(1), 10-5. https://doi.org/10.1016/j.ypmed.2010.09.016
Viera AJ, et al. Acceptance of a Polypill Approach to Prevent Cardiovascular Disease Among a Sample of U.S. Physicians. Prev Med. 2011;52(1):10-5. PubMed PMID: 20933538.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians. AU - Viera,Anthony J, AU - Sheridan,Stacey L, AU - Edwards,Teresa, AU - Soliman,Elsayed Z, AU - Harris,Russell, AU - Furberg,Curt D, Y1 - 2010/10/08/ PY - 2010/07/01/received PY - 2010/09/27/revised PY - 2010/09/30/accepted PY - 2010/10/12/entrez PY - 2010/10/12/pubmed PY - 2011/4/27/medline SP - 10 EP - 5 JF - Preventive medicine JO - Prev Med VL - 52 IS - 1 N2 - OBJECTIVE: To examine US physicians' self-reported knowledge about the Polypill, factors considered in deciding whether to prescribe it, and acceptance of prescribing it for cardiovascular disease (CVD) prevention. METHODS: Numerical scales of 0 (lowest) to 5 (highest) were used to assess self-reported knowledge and importance of factors relevant to making a decision to prescribe a Polypill. Characteristics of physicians indicating they would prescribe a Polypill were compared. RESULTS: Among 952 physicians surveyed February through March 2010, mean self-rated knowledge about the Polypill was 2.0±1.5. Importance of degree of CVD event reduction, cost, and side effects were rated with means of 4.4, 4.3, and 4.3, respectively. 83% of respondents indicated they would "definitely" or "probably" prescribe it for high-risk patients; 62% would do so for moderate risk patients. Physicians with self-rated knowledge at ≥75th percentile were more likely to indicate they would prescribe a Polypill for moderate risk (adjusted OR 2.16; 95% CI 1.60-2.93) and high-risk (adjusted OR 1.57; 95% CI 1.07-2.32) patients. CONCLUSION: Among this sample of physicians, there is relatively high acceptance of prescribing a Polypill for CVD prevention despite relatively modest knowledge about it. SN - 1096-0260 UR - https://www.unboundmedicine.com/medline/citation/20933538/Acceptance_of_a_Polypill_approach_to_prevent_cardiovascular_disease_among_a_sample_of_U_S__physicians_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0091-7435(10)00377-4 DB - PRIME DP - Unbound Medicine ER -